Castle Biosciences, Inc. Common Stock Share Price
NASDAQ: CSTLHealthcare
Live Castle Biosciences, Inc. Common Stock Share Price Chart
O H L
Castle Biosciences, Inc. Common Stock Performance Overview
Days Range
▼
$35.97Low
$36.47High
Markets Today
| Previous Close | $36.78 |
|---|---|
| Open | $36.47 |
| Volume | 37,487 |
| Day's Range | $35.97 - $36.47 |
| 52W Range | $17.72 - $44.28 |
| Market Cap | $1.08 B |
Historical Performance
| 1M Returns | +26.70 |
|---|---|
| 3M Returns | +74.15 |
| 6M Returns | +43.59 |
| 1Y Returns | +56.78 |
| 5Y Returns | -52.43 |
| 10Y Returns | NA |
Castle Biosciences, Inc. Common Stock Fundamentals
| Market Cap | $1.08 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $344.23 M |
| ROE TTM | -0.05 |
| EPS TTM | $-0.65 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.30 |
| EBITDA | $-2.04 M |
| Profit Margin | -7.02 |
| Market Cap | $1.08 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $344.23 M |
| ROE TTM | -0.05 |
| EPS TTM | $-0.65 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.30 |
| EBITDA | $-2.04 M |
| Profit Margin | -7.02 |
Castle Biosciences, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $87.99 M | $86.19 M | $83.04 M | $87.01 M | $83.68 M | $103.55 M |
| Gross Profit + | $71.61 M | $68.56 M | $64.34 M | $68.69 M | $63.15 M | $79.85 M |
| Operating Income | -$27.93 M | -$4.25 M | -$6.80 M | -$3.83 M | -$18.41 M | -$3.07 M |
| EBITDA | $1.84 M | -$837.00 K | -$2.99 M | -$50.00 K | -$14.48 M | $1.00 M |
| Interest Expense | -$17.00 K | -$21.00 K | -$24.00 K | -$24.00 K | -$134.00 K | -$193.00 K |
| Depreciation | $29.76 M | $3.41 M | $3.82 M | $3.78 M | $3.93 M | $4.07 M |
| Income Before Tax | -$26.27 M | -$143.00 K | -$386.00 K | -$2.71 M | -$14.41 M | -$1.69 M |
| Income Tax Expense | -$423.00 K | -$4.67 M | $115.00 K | -$382.00 K | $109.00 K | $370.00 K |
| Net Income + | -$25.85 M | $4.52 M | -$501.00 K | -$2.33 M | -$14.52 M | -$2.06 M |
| Net Profit Margin | -29.38% | 5.25% | -0.6% | -2.68% | -17.35% | -1.99% |
Castle Biosciences, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $29.00 K | $29.00 K | $29.00 K | $30.00 K | $30.00 K | $31.00 K |
| Reserve & Surplus | -$225.84 M | -$221.41 M | -$221.71 M | -$224.02 M | -$238.87 M | -$241.12 M |
| Non-Current Liabilities | $24.14 M | $38.46 M | $40.43 M | $39.01 M | $37.63 M | $34.64 M |
| Current Liabilities | $37.27 M | $50.89 M | $55.31 M | $68.68 M | $48.76 M | $56.51 M |
| Total Liabilities | $61.41 M | $89.35 M | $95.74 M | $107.68 M | $86.39 M | $91.15 M |
| Fixed Assets | $133.33 M | $178.19 M | $186.73 M | $197.02 M | $198.28 M | $199.78 M |
| Current Assets | $349.39 M | $348.67 M | $357.57 M | $361.10 M | $328.90 M | $341.10 M |
| Total Assets | $501.71 M | $544.73 M | $562.79 M | $578.56 M | $547.80 M | $561.18 M |
Castle Biosciences, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$25.85 M | $4.52 M | -$501.00 K | -$2.33 M | -$14.52 M | -$2.06 M |
| Operating Cash Flow | -$6.04 M | $20.82 M | $22.63 M | $26.93 M | -$22.13 M | $15.20 M |
| Investing Cash Flow | -$22.43 M | -$28.38 M | -$18.39 M | $8.83 M | -$25.80 M | -$15.96 M |
| Financing Cash Flow | -$1.55 M | $101.00 K | -$919.00 K | -$4.59 M | -$5.03 M | -$886.00 K |
| Change in Cash | -$30.02 M | -$7.46 M | $3.32 M | $31.17 M | -$52.97 M | -$1.65 M |
Castle Biosciences, Inc. Common Stock Return Calculator
The Castle Biosciences, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$4,615
Invested Amount$10,000
Est. Returns$-5,385
About Castle Biosciences, Inc. Common Stock
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Popular Stocks
FAQs
What is the share price of Castle Biosciences, Inc. Common Stock today?
Castle Biosciences, Inc. Common Stock (CSTL) share price as of September 18, 2026 is $35.68. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Castle Biosciences, Inc. Common Stock?
Yes, Indian Investors can invest in the Castle Biosciences, Inc. Common Stock (CSTL) Share by opening an international trading account with Angel One.
How can I purchase Castle Biosciences, Inc. Common Stock shares in India?
Purchasing Castle Biosciences, Inc. Common Stock (CSTL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Castle Biosciences, Inc. Common Stock (CSTL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Castle Biosciences, Inc. Common Stock?
Yes, you can purchase fractional shares of Castle Biosciences, Inc. Common Stock (CSTL) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Castle Biosciences, Inc. Common Stock?
The market capitalization of Castle Biosciences, Inc. Common Stock on September 18, 2026, is $1.08 B.
In which sector Castle Biosciences, Inc. Common Stock belongs?
Castle Biosciences, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Castle Biosciences, Inc. Common Stock stocks?
In order to invest in Castle Biosciences, Inc. Common Stock (CSTL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
